---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-25-002373"
form_type: "8-K"
ticker: "CNSP"
cik: "0001729427"
company_name: "CNS Pharmaceuticals, Inc."
filed_at: "2025-04-09T23:59:59+00:00"
generated_at: "2026-05-23T18:28:16.166219+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "low"
source: SEC EDGAR
---

# CNS Pharmaceuticals releases April 2025 investor presentation; no specific news disclosed

## Summary
- Presentation dated April 2025 furnished under Regulation FD for investor meetings.
- Filing does not include any financial results, pipeline updates, or clinical data.
- Company ticker CNSP listed; no material new information beyond presentation format.
- Confidence low because exhibit content beyond title page was not provided.

## SEC filing metadata
- accession: 0001683168-25-002373
- form_type: 8-K
- ticker: CNSP
- cik: 0001729427
- company_name: CNS Pharmaceuticals, Inc.
- filed_at: 2025-04-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1729427/000168316825002373/0001683168-25-002373-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1729427/000168316825002373/cns_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-25-002373
- JSON: https://secwatch.observer/filing/0001683168-25-002373.json
- Plain text: https://secwatch.observer/filing/0001683168-25-002373.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.